Pub. Date : 2021 Apr 29
PMID : 33910628
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report. | Tamoxifen | nuclear receptor subfamily 4 group A member 1 | Homo sapiens |
| 2 | We describe the case of a patient who was treated successfully with tamoxifen for her hormone-receptor-positive breast cancer and acromegaly. | Tamoxifen | nuclear receptor subfamily 4 group A member 1 | Homo sapiens |
| 3 | CONCLUSION: This case highlights the dual benefit of tamoxifen therapy in the treatment of hormone-receptor-positive breast cancer and acromegaly. | Tamoxifen | nuclear receptor subfamily 4 group A member 1 | Homo sapiens |
| 4 | Unlike anastrozole, tamoxifen has the benefit of lowering insulin-like growth factor 1 levels, which underscores its advantage in reducing adverse musculoskeletal symptoms during the treatment of hormone-receptor-positive breast cancer. | Tamoxifen | nuclear receptor subfamily 4 group A member 1 | Homo sapiens |
| 5 | We offer the first reported use of tamoxifen monotherapy for the successful treatment of acromegaly and hormone-receptor-positive breast cancer. | Tamoxifen | nuclear receptor subfamily 4 group A member 1 | Homo sapiens |